women in the United States are newly diagnosed with ovarian cancer and nearly 13,000 die — more than from any other reproductive system cancer.
Today, there is no ovarian cancer screening test. Our technology is not a screening test. It is for women who present with a pelvic mass. Because you cannot biopsy the pelvic cavity, doctors need to determine if it's a low-risk mass or a high-risk mask. And it's literally a difference of whether you will have your surgery done by a generalist or whether you need to get one of 1,000 specialists in the country. It really is a difference between a good prognosis and a poor prognosis.
Keep a journal so when you go, you can say, “I've had pain six out of seven days. I didn't have this pain a month ago. There's something wrong.”